WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'6501 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 9'2351 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 3'834  3'839  3'846  3'853  3'861  3'834  4'527  4'100 
Births 34  34  33  33  33  38  64  77 
Surviving infants 34  33  33  33  32  38  63  75 
Pop. less than 5 years 158  159  166  169  172  237  368  369 
Pop. less than 15 years 622  644  669  682  693  773  1'100  1'135 
Female 15-49 years 945  950  954  961  970  1'042  1'216  1'142 

Number of reported case

(Click for retrospective incidence data for Bosnia and Herzegovina)
Diphtheria
Japanese encephalitis
Measles 22  10  45  22  43  512 
Mumps 7'881  8'209  209  474  54  3'577 
Pertussis 19  30  30  25  41  43  287 
Polio*
Rubella 17  31  2'784  523  19  144 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bosnia and Herzegovina)
Vaccine year result method % card seen                                                
BCG 2010  99  MICS   91.4  96  94  99  97  96  93 
DTP1 2010  98  MICS   91.4  95  94  89  95  95  90 
DTP3 2010  92  MICS   91.4  92  88  89  90  91  85 
HepB_BD          96  95  95  97  96 
HepB3          92  88  90  90  88  85 
Hib3          87  85  84  80  83 
JapEnc         
MCV 2010  88  MICS   91.4  94  89  92  93  84  80 
MCV2          94  88  91  88  92  74 
PCV1         
PCV3         
Pol3 2010  91  MICS   91.4  87  89  91  90  92  87 
Rota1         
Rota_last         
Rubella1         
TT2plus          94  87 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bosnia and Herzegovina)
BCG 96  94  96  97  96  93 
DTP1 95  94  95  95  95  90 
DTP3 92  88  89  90  91  85 
HepB3 92  88  89  90  88 
Hib3 87  85  83  80  83 
MCV 94  89  91  93  84  80 
PCV3
Pol3 87  89  90  90  92  87 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years;
DTP 3, 4, 6, 18 months;
DTPHibIPV 3, 4, 5 months;
DTaPIPV 2, 4, 6 months; 5 years; No or o1 dose at year 5
HepB birth; 1-2, 6 months; Yes
Hib 2-3, 3-5, 6-18, 18 months; or 1 dose at year 2
IPV 3, 4, 5 months; 5 years;
MMR 12 or 13 or 18 months; 6 years; No
OPV 18 months; 14 years; or 2, 14 years
TT 18 years; No
Td 14 years; No

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  Yes  Yes  Yes 
What years does the MYP cover? number         2001-2006  2002-2004  2001-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 10  10  18  16  10  18  18 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number   18  18  16  10  18  18 
Nº districts with DTP3 coverage >=80% number   17  16  10  18  18 
% of districts with DTP3 coverage >=80% From 0 to 100%   94  89  56  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%   39  33  13     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   NA    95  82  95  90 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.